These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10754699)

  • 1. Aseptic process monitoring--a better strategy. Validation Group, Inc.
    Wilson JD
    PDA J Pharm Sci Technol; 1999; 53(3):111-4. PubMed ID: 10754699
    [No Abstract]   [Full Text] [Related]  

  • 2. Good validation practices: FDA issues.
    Levchuk JW
    PDA J Pharm Sci Technol; 1994; 48(5):221-3. PubMed ID: 8000894
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of packaging in ethylene oxide sterilization.
    Panella JA
    Bull Parenter Drug Assoc; 1974; 28(4):188-96. PubMed ID: 4212326
    [No Abstract]   [Full Text] [Related]  

  • 4. [Validation of sterile pharmaceutical production. Considerations and experiences].
    Pongiluppi S
    Boll Chim Farm; 1985 Jul; 124(7):293-305. PubMed ID: 4074520
    [No Abstract]   [Full Text] [Related]  

  • 5. Validation: an unconventional review and reinvention.
    Agalloco J
    PDA J Pharm Sci Technol; 1995; 49(4):175-9. PubMed ID: 7552236
    [No Abstract]   [Full Text] [Related]  

  • 6. Combating counterfeit drugs.
    Lancet; 2008 May; 371(9624):1551. PubMed ID: 18468523
    [No Abstract]   [Full Text] [Related]  

  • 7. Top ten hot topics in parenteral science and technology.
    Akers MJ; Nail SL; Saffell-Clemmer W
    PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticipated revisions to the current good manufacturing practice regulations.
    Mitchell CM
    Bull Parenter Drug Assoc; 1974; 28(3):146-51. PubMed ID: 4845938
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry perspective on the medical risk of visible particles in injectable drug products.
    Bukofzer S; Ayres J; Chavez A; Devera M; Miller J; Ross D; Shabushnig J; Vargo S; Watson H; Watson R
    PDA J Pharm Sci Technol; 2015; 69(1):123-39. PubMed ID: 25691720
    [No Abstract]   [Full Text] [Related]  

  • 10. Gamma sterilization of pharmaceuticals--a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations.
    Hasanain F; Guenther K; Mullett WM; Craven E
    PDA J Pharm Sci Technol; 2014; 68(2):113-37. PubMed ID: 24668600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 12. Environmental microbial challenges to an aseptic Blow-Fill-Seal process--a practical study.
    Jones DJ; Topping P; Sharp J
    PDA J Pharm Sci Technol; 1995; 49(5):226-34. PubMed ID: 7489196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDA comments: PIC draft recommendations on the inspection of isolator technology. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1999; 53(3):141-7. PubMed ID: 10754704
    [No Abstract]   [Full Text] [Related]  

  • 14. Sterility failure analysis.
    Schroeder HG
    PDA J Pharm Sci Technol; 2005; 59(2):89-95. PubMed ID: 15971541
    [No Abstract]   [Full Text] [Related]  

  • 15. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 16. Need for specific-gravity values in adopting gravimetric measurement in sterile compounding.
    Roberts PA; Valgus JM; Willoughby IR; Amerine LB
    Am J Health Syst Pharm; 2017 Jun; 74(12):871-872. PubMed ID: 28596223
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality risk management for aseptic processes. Technical report No. 44.
    PDA J Pharm Sci Technol; 2008; 62(1 Suppl TR44):2-39. PubMed ID: 18575382
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA's aseptic processing: proposed regulation.
    Barr DB
    J Parenter Sci Technol; 1993; 47(2):57-9. PubMed ID: 8515345
    [No Abstract]   [Full Text] [Related]  

  • 19. Cleaner medicaments.
    Br Med J; 1973 Apr; 2(5857):6. PubMed ID: 4695717
    [No Abstract]   [Full Text] [Related]  

  • 20. Filling vials aseptically while monitoring for bacterial contamination.
    Dirksen JW; Larsen RV
    Am J Hosp Pharm; 1975 Oct; 32(10):1031-2. PubMed ID: 1190216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.